Concepedia

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann, Philipp Harter, Florence Joly, Jalid Sehouli, Ulrich Canzler, Barbara Schmalfeldt, Andrew P Dean, Alexander Hein,

The Lancet Oncology · 2020 · 162 citations · 22 references

DOI

Concepts

References

22

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

, , +17

EORTC QLQ-C30 Scoring Manual

Peter Fayers, Neil K. Aaronson, Kristin Bjordal et al. · Research at the University of Copenhagen (University of Copenhagen) · 1995 · 2.4K citations

, , +2

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +15

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata et al. · New England Journal of Medicine · 2019 · 2K citations · Full text

, , +14

Checking the Cox model with cumulative sums of martingale-based residuals

D. Y. Lin, L. J. Wei, Z. Ying · Biometrika · 1993 · 1.4K citations

, , +16